THIS NOVEL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain tumor known for its fast growth and unresponsiveness to typical treatments. Investigations are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is abundantly produced in gliob